| DA-associated environment | Pitx3-dependent DA-associated VM tissue → migrating GABAergic cells | Mouse; Pitx3-deficient aphakia embryo, explant, and transplantation | Loss-of-function; migration assay; environmental rescue | Reduced GABAergic accumulation and abnormal positioning; neurogenesis preserved | Direct tissue-level cross-population evidence in embryonic VM | Moderate–high for an environmental effect | Cellular source and molecular mediator remain unresolved |
| Netrin-1 | Axon-delivered forebrain Netrin-1 → DSCAM-expressing SIX3-positive anterior SNpr GABAergic precursors | Mouse embryo; conditional Ntn1 source manipulations and Dscam/Dcc mutants | Source-specific loss-of-function; receptor loss-of-function; 3D migration phenotyping | Reduced ventral migration of anterior SNpr GABAergic cells; secondary ventral dispersion of DA neurons | Direct source- and receptor-resolved evidence in embryonic substantia nigra | Moderate–high for GABAergic migration; moderate for cross-population organization | DSCAM, not DCC, mediates the SNpr GABAergic response; no direct GABA-derived signal to DA neurons identified |
| CXCL12/CXCR4 | Meningeal CXCL12 → CXCR4-expressing differentiating DA neurons | Mouse embryo; Cxcr4 mutant and tissue assays | Loss-of-function; descriptive localization | Altered initial radial migration, trajectory, and final DA distribution | Direct DA-lineage evidence in embryonic VM | Low or emerging for DA-GABA coordination | Comparable VM GABAergic target has not been demonstrated |
| Reelin-ApoER2/VLDLR-Dab1 | Reelin → receptor/Dab1 signaling in laterally migrating DA neurons | Mouse embryo; reeler and Dab1-pathway models | Loss-of-function; migration phenotyping | Impaired rapid lateral migration and SNpc organization | Direct DA-lineage evidence in embryonic VM | Low or emerging for DA-GABA coordination | Direct effect on VM GABAergic migration has not been established |
| CAMs/integrins | Adhesion molecules and integrin-ECM interactions → migrating/differentiating neural cells | Predominantly rodent cortical and general CNS models | Loss-/gain-of-function and descriptive studies | Adhesion, migration, neurite extension, and tissue organization | Mostly indirect, non-VM mechanistic evidence | Low or emerging | Direct VM-specific cross-population evidence is limited |
| Radial glia and ECM | Rgl subtypes/floor-plate radial glia and related ECM factors → developing neurons | Mouse and human fetal VM; human stem-cell-derived DA cultures | Lineage tracing; single-cell profiling; descriptive and selected functional assays | DA lineage production, survival, signaling, and tissue organization | VM-specific lineage/transcriptomic evidence with selected in vitro function | Moderate; strongest for DA development | In vivo effects on both neuronal populations require testing |
| Cell-cell communication | Predicted ligand-producing and receptor-expressing neuronal and non-neuronal populations | Mouse/human single-cell and spatial datasets; computational models | Descriptive profiling and inferential ligand-receptor analysis | Candidate regulation of migration, differentiation, support, and organization | VM profiling plus general computational/spatial inference | Low or emerging; inference-dominated | Secretion, receptor activation, necessity, phenotype, and rescue remain to be demonstrated |
| Vascular-derived signaling | Endothelial/vascular-associated cells → neural progenitors and developing neurons | Predominantly rodent cortical and broader-CNS models | Descriptive, loss-of-function, and inferential studies | Metabolic support, survival, ECM organization, and candidate signaling | Primarily broader-CNS evidence | Low or emerging in the VM | VM-specific endothelial perturbation with simultaneous DA/GABA phenotyping is needed |